Fridell, Jonathan A.Bozic, Molly A.Ulrich, Benjamin J.Lutz, Andrew J.Powelson, John A.2022-02-042022-02-042021-09Fridell, J. A., Bozic, M. A., Ulrich, B. J., Lutz, A. J., & Powelson, J. A. (2021). Pancreas transplantation for Cystic Fibrosis: A Frequently Missed Opportunity. Clinical Transplantation, 35(9), e14371. https://doi.org/10.1111/ctr.143711399-0012https://hdl.handle.net/1805/27700Cystic fibrosis (CF) is an inherited autosomal recessive disorder. Despite optimized therapy, the majority of affected individuals ultimately die of respiratory failure. As patients with CF are living longer, extra-pulmonary manifestations may develop including pancreatic failure, which manifests as exocrine insufficiency, and CF related diabetes (CFRD). Both of these can be managed through pancreas transplantation. Pancreas transplantation is usually performed in combination with another organ, most often with a kidney transplant for end-stage diabetic nephropathy. In the CF patient population, the two settings where inclusion of a pancreas transplant should be considered would be in combination with a lung transplant for CF pulmonary disease, or in combination with a liver for CF related liver disease with cirrhosis. This report will discuss this topic in detail, including a review of the literature regarding combinations of lung/pancreas and liver/pancreas transplant.enPublisher PolicyCystic FibrosisLiver TransplantCystic Fibrosis Related DiabetesArticle